- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.08. | Sona Nanotech Inc: Sona Nanotech closes $2.52-million private placement | 1 | Stockwatch | ||
| 11.08. | Sona Nanotech Closes Over-Subscribed Private Placement Financing to Raise $2,527,012 in Gross Proceeds | 1 | CNW | ||
| 31.07. | Sona Nanotech Inc: Sona Nanotech arranges $2.4-million private placement | 1 | Stockwatch | ||
| 31.07. | Sona Nanotech To Arrange Private Placement Financing | 1 | CNW | ||
| 11.06. | Sona Nanotech Inc: Sona Nanotech appoints Fleming director | 1 | Stockwatch | ||
| 11.06. | Sona Nanotech Appoints Seasoned Biotech Commercial Executive Michael A. Fleming to Board of Directors | 1 | CNW | ||
| 05.05. | Sona Nanotech Announces Clinical Strategy With Two THT Combination Therapy Studies In Melanoma | 4 | CNW | ||
| SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
| 27.04. | Sona Nanotech Showcases Cancer Therapy Results At Prestigious Industry Cancer Conferences | 1 | CNW | ||
| 16.04. | Sona Nanotech Inc: Sona Nanotech appoints Smylie, Trites to advisory board | 1 | Stockwatch | ||
| 16.04. | Sona Nanotech Announces Appointment of Two Leading Oncologists To Its Scientific Advisory Board | 1 | CNW | ||
| 13.04. | Sona Nanotech Inc: Sona Nanotech upbeat about THT's effect on tumours | 2 | Stockwatch | ||
| 13.04. | Sona Nanotech Clinical Cancer Study Tissue Analysis Confirms Tumor Priming And Suggests Potential Immunotherapy Synergies | 2 | CNW | ||
| 08.04. | Sona Nanotech Inc: Sona says THT shows strong combo cancer efficacy | 3 | Stockwatch | ||
| 07.04. | Sona Nanotech's THT Cancer Therapy Demonstrates Strong Efficacy And Durability In Combination with Immunotherapy In Peer-reviewed Preclinical Study | 1 | CNW | ||
| 17.03. | Sona Nanotech Inc: Sona Nanotech to hold investor webinar March 18 | 3 | Stockwatch | ||
| 16.03. | Sona Nanotech To Hold Investor Webinar To Discuss Follow-up Data From First-in-human Cancer Therapy Study | 1 | CNW | ||
| 20.10.25 | Sona Nanotech Inc.: Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study | 787 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 20, 2025) - Sona Nanotech Inc., (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is pleased to announce the completion of its first-in-human clinical... ► Artikel lesen | |
| 17.10.25 | Sona Nanotech Inc.: Sona Nanotech To Host Investor Webinar To Discuss Clinical Study | 1.342 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 17, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), announces that it will host a webinar on Monday, October 20th at noon... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 20,450 | -0,73 % | Formycon Aktie: Dieser Umsatzsprung macht Analysten mutig | ||
| ONTO INNOVATION | 229,30 | -0,61 % | If You Invested $1000 In Onto Innovation Stock 10 Years Ago, You Would Have This Much Today | ||
| RIBER | 9,130 | +7,41 % | RIBER: FIRST-HALF 2026 BUSINESS ACTIVITY Business growth, resilient order book and continued rollout of ROSIE | FIRST-HALF 2026 BUSINESS ACTIVITYBusiness growth, resilient order book and continued rollout of ROSIE Bezons, July 22, 2026 - 8:00 am - RIBER, the global leader in molecular beam epitaxy (MBE) equipment... ► Artikel lesen | |
| VEECO INSTRUMENTS | 36,880 | -4,08 % | Veeco Instruments Inc.: Veeco Reports Second Quarter 2026 Financial Results | Second Quarter 2026 Highlights: Revenue of $193.5 million, compared with $166.1 million in the same period last yearGAAP net income of $11.9 million, or $0.18 per diluted share, compared with $11.7... ► Artikel lesen | |
| GOMSPACE | 0,994 | +0,61 % | GomSpace A/S: D-Orbit Selects GomSpace Power Systems for Upcoming Space Logistics Missions | STOCKHOLM, Sept. 1, 2026 /PRNewswire/ -- GomSpace, leading provider of pre-engineered products for space missions, announced that D-Orbit, a global leader in space logistics and orbital transportation... ► Artikel lesen | |
| GAUZY | 0,390 | -0,89 % | Gauzy Ltd. - 6-K, Report of foreign issuer | ||
| SOLESENCE | 0,849 | 0,00 % | Solésence, Inc.: Solésence Reports Second Quarter 2026 Financial Results | Quarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically... ► Artikel lesen | |
| KOPIN | 3,632 | -1,33 % | Fabric.AI (Nasdaq: FABC) Stockholders Ratify Kopin Strategic Partnership to Develop Neural I/o MicroLED Optical Interconnect Technology for Next Generation AI Data Centers | NEW YORK, NY, June 24, 2026 (GLOBE NEWSWIRE) -- Fabric.AI, Inc. (Nasdaq: FABC) ("Fabric.AI" or the "Company"), a fabless semiconductor company developing MicroLED-based optical interconnects for AI... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,100 | -14,53 % | FendX Technologies Inc.: FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program | Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection... ► Artikel lesen | |
| NVE | 87,00 | 0,00 % | Dividendenbekanntmachungen (03.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,026 EUR BF SPA IT0005187460 - 0,038 EUR CITIZENS & NORTHERN CORPORATION US1729221069 0... ► Artikel lesen | |
| ZENTEK | 0,460 | -3,36 % | Zentek Ltd: Zentek corrects OTC listing date to Wednesday, Sept. 2 | ||
| SMOLTEK NANOTECH | 0,115 | +2,68 % | SMOLTEK NANOTECH HOLDING AB: Smoltek appoints Gabriel Altby as Chief Operating Officer | ||
| NANOVIRICIDES | 0,970 | +2,11 % | While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles | SHELTON, CT / ACCESS Newswire / August 31, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development... ► Artikel lesen | |
| XTPL | 17,460 | 0,00 % | EQS-News: XTPL S.A.: XTPL is in the process of securing a strategic investor from Taiwan to strengthen its position in the semiconductor market | Issuer: XTPL S.A.
/ Key word(s): Capital Increase/Agreement
XTPL is in the process of securing a strategic investor from Taiwan to strengthen its position in the semiconductor... ► Artikel lesen | |
| LAMPETIA | 0,177 | +9,94 % | EQS-Adhoc: Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Sonstiges
Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten
16.07.2026 / 22:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen |
SONA NANOTECH INC gehört der Branche Nanotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SONA NANOTECH INC finden Sie auf Wallstreet Online.